Walleye Trading LLC Tricida, Inc. Transaction History

Walleye Trading LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$8.51 - $13.6 $630,684 - $1.01 Million	74,111 New	74,111 $777,000
Q3 2021 Nov 15, 2021	SELL	$3.56 - $4.64 $66,849 - $87,129	-18,778 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$3.95 - $5.41 $74,173 - $101,588	18,778 New	18,778 $81,000
Q1 2021 May 17, 2021	SELL	$4.52 - $7.8 $17,890 - $30,872	-3,958 Closed	0 $0
Q4 2020 Feb 16, 2021	SELL	$4.37 - $9.46 $94,676 - $204,950	-21,665 Reduced 84.55%	3,958 $28,000
Q3 2020 Nov 16, 2020	BUY	$8.56 - $26.93 $219,332 - $690,027	25,623 New	25,623 $232,000

30K

124K

46.5K

Ticker TCDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,668,900
Market Cap $557K
Description
Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company ...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.